Balcom Alexandra 4
4 · Nuvalent, Inc. · Filed Dec 10, 2025
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Balcom Alexandra
Chief Financial Officer
Transactions
- Sale
Class A Common Stock
2025-12-08$110.31/sh−6,984$770,405→ 54,750 total - Sale
Class A Common Stock
2025-12-08$111.32/sh−100$11,132→ 54,650 total
Footnotes (3)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.98, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.22 to $111.42, inclusive.